Patents
Patents for C07C 237 - Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups (16,118)
07/2003
07/22/2003US6596693 Dipeptide apoptosis inhibitors and the thereof
07/17/2003WO2003057721A2 Substituted amino carboxamides for the treatment of alzheimer's disease
07/17/2003WO2003057169A2 4-dedimethylamino tetracycline compounds
07/17/2003WO2003057164A2 Compounds for delivering substances into cells
07/17/2003WO2003003987A3 Solid phase synthesis of arylretinamides
07/17/2003US20030135066 Renin inhibitors for the treatment of hypertension and glaucoma.
07/17/2003US20030134874 Multicyclic compounds which inhibit leukocyte adhesion mediated by VLA-4
07/17/2003US20030134423 Lipid aggregates (liposomes) for transfection of nucleic acids
07/17/2003US20030133953 Complexing a biologically active agent with a perturbant to reversibly transform and exposing a membrane or bilayer to the supramolecular complex
07/17/2003CA2472617A1 Substituted amino carboxamides for the treatment of alzheimer's disease
07/16/2003EP1326840A2 Substituted heterocyclic compounds for treating multidrug resistance
07/16/2003EP1326834A2 2-substituted heterocyclic compounds
07/16/2003EP1326833A2 Substituted heterocyclic compounds for treating multidrug resistance
07/16/2003EP1326827A2 Insecticidal 1,8-naphthalenedicarboxamides
07/16/2003CN1430600A 7-and 9-carbamate, urea, thiourea, thiocarbamate and heteroaryl-amino substituted tetracycline compounds
07/16/2003CN1430597A Novel MMP-2/MMP-9 inhibitors
07/16/2003CN1114637C Method of reactive amine catalysts for use in polyurethane formation
07/15/2003US6593312 Cyclic α-amino-γ-hydroxyamide compounds
07/15/2003CA2128942C Process for the crystallization of iopamidol
07/10/2003WO2001098248A3 Hiv integrase inhibitors
07/10/2003WO2001096297A3 Antipicornaviral compounds and compositions, their pharmaceutical uses, and materials for their synthesis
07/10/2003US20030130522 Renin inhibitors; treating cardiovascular disorders and glaucoma
07/10/2003US20030130349 Inhibitors of alpha 4beta1 mediated cell adhesion
07/10/2003US20030130320 Alpha 4 integrin antagonists
07/10/2003US20030130295 Substituted 2-aminoacetamides and the use thereof
07/10/2003US20030130272 Topoisomerase inhibitor; viricides
07/10/2003US20030130237 Lysophosphatidic acid receptor antagonist; anticancer agents
07/10/2003US20030130236 Method and compositions for treating persistent pulmonary hypertension using aralkyl ester soft drugs
07/09/2003EP1165496B1 Substituted aniline compounds
07/09/2003EP1040096B1 Neuroprotective agents
07/09/2003CN1429200A Anthranyl amides and their use as medicaments
07/09/2003CN1429199A Insecticidal 1,8-naphthalenedicarboxamides
07/09/2003CN1429106A Methods for inhibiting angiogenesis and tumor growth
07/09/2003CN1113864C Process for preparing caprolactam using 6-aminocapronitrile
07/08/2003US6590118 Used in treatment of and/or prevention of diabetes, especially non-insulin dependent diabetes (Type 2 diabetes)
07/03/2003WO2003053912A1 α-(N-SULPHONAMIDO)ACETAMIDE DERIVATIVES AS β-AMYLOID INHIBITORS
07/03/2003US20030125489 Open chain alkoxyamine compounds and their use as polymerization regulators
07/03/2003US20030125392 Method for producing acetoacetylated aromatic amines
07/03/2003US20030125348 Minocycline compound substitued at 9-position by a group selected from nitro, alkyl, alkenyl, alkynyl, aryl, alkoxy, alkylthio, alkylsufinyl, alkylsulfonyl, amino, thionitroso, arylalkynyl or carbamate, urea, and sulfonamide
07/03/2003US20030125329 Treating atherosclerosis and other coronary artery diseases
07/03/2003US20030125328 Treating atherosclerosis and other coronary artery diseases
07/03/2003US20030125315 Providing a focused approach that permits a more rapid screening of probes with potential for association with a particular binding site with a higher likelihood of success; combinatorial chemistry; screening; computer software
07/02/2003EP1322599A2 Hiv integrase inhibitors
07/02/2003EP1322598A1 Nitroso diphenylamine derivatives
07/02/2003EP0944582B1 Ketobenzamides as calpain inhibitors
07/02/2003EP0848700B1 Acylaminosalicylic acid amides and their uses as pesticides
07/02/2003CN1113055C Continuous preparation of aqueous mixture of epsilon-caprolactam and its precursors
07/01/2003US6586475 5-chloro-N-(2-N,N-diethylamino)ethyl)-2- methoxy-4-(1-naphthoylamino)benzamide and prodrugs, used for prevention of neurodegenarative diseases such as Alzheimer's disease
07/01/2003US6586467 Tyrosine phosphatase inhibitors useful in the treatment or prevention of Type II Diabetes Mellitus
07/01/2003US6586433 Anticholesterol agents; antilipemic agents; cardiovascular disorders
06/2003
06/26/2003WO2003051357A1 Glucagon receptor antagonists/inverse agonists
06/26/2003US20030120080 Such as (2S)-2-((4S)-4-(2,2-difluorovinyl)-2-oxopyrrolidinyl) butanamide; antiepileptic agents; anticonvulsants
06/26/2003US20030120034 N-(2-hydroxyethyl)-2,4,6-triiodo-5-(2-(2,4,6-triiodo-3-(N-meth yl acetamido)-5-(methylcarbamyl)benzamidoacetamido)-isophthalmic acid, derivatives
06/26/2003US20030119982 Wet adhesion monomer and derived copolymers for latex paints
06/26/2003US20030119833 Treating cardiovascular diseases
06/25/2003EP1320538A2 Process for the preparation of 5-phenylpentanoyl-ala-argl-ala- 2-[3-amino-2-oxopyrrolidin-1-yl]propionyl - ala-arg-ala-4-aminophenylacetamide
06/25/2003EP1075462B1 Process for the preparation of s- n,n'- bis[2- hydroxy-1- (hydroxymethyl) ethyl]-5- [(2- hydroxy-1- oxopropyl)- amino]- 2,4,6- triiodo- 1,3- benzenedicarboxamide
06/25/2003CN1426391A Polyamine analogues as cytotoxic agents
06/24/2003US6583301 Lipids
06/24/2003US6583183 Substituted n-phenyl-n-fused-benzyl aminoalcohol compounds useful for inhibiting cholesteryl ester transfer protein activity
06/24/2003US6583179 Substituted aminoalkylamide derivatives as antagonists of follicle stimulating hormone
06/24/2003CA2126337C 2-amino-1,3-propanediol compound and immunosuppressant
06/19/2003US20030114508 Fused imidazolium derivatives
06/19/2003US20030114454 Substituted polycyclic aryl and heteroaryl tertiary-heteroalkylamines useful for inhibiting cholesteryl ester transfer protein activity
06/19/2003US20030114447 Controlling apoptosis; central nervous system disorders
06/18/2003EP1318977A1 Substituted phenylcyclohexane carboxylic acid amides and the use thereof
06/18/2003EP1140829A4 Contrast media for angiography
06/18/2003CN1425031A Compositions comprising antioxidant amines based on N-(4-anilinophenyl) amides
06/18/2003CN1111520C Matrix metalloprotease inhibitors
06/17/2003US6579890 Matrix metalloprotease inhibitors
06/17/2003US6579872 Bezamide derivatives for the treatment of diseases mediated by cytokines
06/12/2003WO2003048108A2 Compounds for treatment of inflammation, diabetes and related disorders
06/12/2003WO2003048106A2 1,3-diarylprop-2-en-1-ones, compositions containing same and use thereof
06/12/2003WO2003048080A1 Methods for the separation of isomers
06/12/2003WO2003047499A2 Amphiphilic compounds and vesicles/liposomes for organ-specific drug targeting
06/12/2003US20030109528 Substituted polycyclic aryl and heteroaryl tertiary-heteroalkylamines useful for inhibiting cholesteryl ester transfer protein activity
06/12/2003US20030109459 Activity as inhibitors of binding between VCAM-1 and cells expressing VLA-4. Such compounds are useful for treating diseases whose symptoms and/or damage are related to the binding of VCAM-1 to cells expressing VLA-4.
06/12/2003US20030108892 Exciplexes
06/12/2003CA2469193A1 1,3-diarylprop-2-en-1-ones, compositions containing same and use thereof
06/11/2003EP1317424A2 Polyamine analogues as therapeutic and diagnostic agents
06/11/2003EP1317421A1 2-amino-2-alkyl-5 heptenoic and heptynoic acid derivatives useful as nitric oxide synthase inhibitors
06/11/2003EP1317414A2 Gamma-ketoacid dipeptides as inhibitors of caspase-3
06/11/2003CN1423641A Quaternary salts of N-substituted cyclic or acyclic amines as pharmaceuticals
06/11/2003CN1423632A Aromatic diamide derivatives or salts thereof, agricultural/norticultural chemicals and method of using the same
06/10/2003US6576791 Local anesthetic compounds and uses
06/10/2003US6576766 Signal transduction inhibitors, compositions containing them
06/10/2003US6576679 Hydrogel
06/10/2003US6576642 Inhibitors of the production of Ig E antibodies, antiallergens
06/10/2003US6576614 Administering methyl ketones or closed hemiketal derivatives of aspartic acid
06/10/2003CA2055670C Retroviral protease inhibiting compounds
06/05/2003WO2003045878A2 2,w-diaminocarboxylic acid compounds
06/05/2003US20030105335 Method for producing beta-alaninamides
06/05/2003US20030105280 Such as N-hydroxysuccinimidyl-5-(N,N-bis-(2-(4-(N-((3-hydroxy-4-(methoxy -carbonyl)phenyl)methyl)carbamoyl) butanoylamino)ethyl)carbamoyl)butanoate for biochemical conjugation
06/05/2003US20030105164 Reacting hexachloroacetone with triphenylphosphine; chlorination of retinoic acid; then aromatic amine; anticancer agents
06/05/2003US20030105100 Substituted polycyclic aryl and heteroaryl tertiary-heteroalkylamines useful for inhibiting cholesteryl ester transfer protein activity
06/05/2003US20030105066 For use in producing antiviral, antifungal and antibacterial medicaments
06/05/2003US20030104360 Synthetic receptors, libraries and uses thereof
06/05/2003US20030102458 Birefringement film
06/05/2003CA2467665A1 2,w-diaminocarboxylic acid compounds
06/04/2003EP1315827A1 Method for the preparation of enantiomerically enriched amines
1 ... 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 ... 162